US stocks move: Eli Lilly rises over 5%, climbs for a second consecutive day to reach highest level since March 16

Glonghui May 1｜Global pharmaceutical giant a certain exchange (LLY.US) surged more than 5% intraday to $984.45, marking its second consecutive day of gains and the highest price since March 16. In terms of news, the exchange recently released results that far exceeded market expectations, with first-quarter revenue of $19.799 billion, up 56% year-on-year, and net profit reaching $7.396 billion, a surge of 168% compared to the same period last year. Its core weight loss drug product contributed over 60% of the income. At the same time, the company announced an upward revision to its full-year performance guidance, raising its expected full-year revenue by $2 billion to $82 billion–$85 billion; the Non-GAAP earnings per share guidance was also raised simultaneously to $35.5–$37.